Novo Nordisk A/S (NVO) |
|
51.308 0.588 (1.16%)
|
03-25 14:08 |
|
Open: |
50.97 |
Pre. Close: |
50.72 |
|
High:
|
51.49 |
Low:
|
50.93 |
|
Volume:
|
979,695 |
Market Cap:
|
122089M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
51.203 - 51.482 |
51.482 - 51.714 |
|
Low:
|
49.999 - 50.354 |
50.354 - 50.649 |
|
Close:
|
50.187 - 50.727 |
50.727 - 51.175 |
|
|
|
Technical analysis |
as of: 2019-03-25 1:31:55 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 61.71 One year: 72.07 |
| Support: |
Support1: 50.22 Support2: 48.60 |
| Resistance: |
Resistance1: 52.83 Resistance2: 61.71 |
| Pivot: |
50.63 |
| Moving Average: |
MA(5): 51.84 MA(20): 50.28
MA(100): 47.22 MA(250): 47.41 |
| MACD: |
MACD(12,26): 0.77  Signal(9): 0.68 |
| Stochastic oscillator: |
%K(14,3): 64.08 %D(3): 76.78 |
| RSI: |
RSI(14): 59.52 |
| 52-week: |
High: 52.83 Low: 41.23 Change(%): 3.8 |
| Average Vol(K): |
3-Month: 135617 10-Days: 109568 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.NVO has closed below upper band by 31.3%. Bollinger Bands are 41.4% wider than normal. The large width of the bands suggest high volatility as compared to NVO's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Fri, 22 Mar 2019 13:15:40 Z
Bull of the Day: DexCom (DXCM)
Thu, 21 Mar 2019 13:17:31 Z
Novo Nordisk A/S (NVO) Ex-Dividend Date Scheduled for March 22, 2019
Wed, 06 Mar 2019 16:08:51 Z
REVIEWAPALOOZA!: 5-Stock Samplers
Tue, 05 Mar 2019 16:10:33 Z
Lilly to Bring Half-Priced Version of Popular Humalog Insulin
Mon, 04 Mar 2019 16:14:06 Z
What's in the Cards for Aeterna (AEZS) This Earnings Season?
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
2388.49 |
| Shares Float (M) |
2388.49 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
8.90 |
|
Shares Short (K)
|
4293 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
2.530 |
|
EPS Est. Current Year
|
2.420 |
|
EPS Est. Next Year
|
2.590 |
|
EPS Est. Next Quarter
|
0.530 |
|
Forward EPS
|
2.780 |
|
Book Value (p.s.)
|
15.840 |
|
PEG Ratio
|
2.29 |
|
Profit Margin
|
34.54 |
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
36.3 |
|
Return on Equity (ttm)
|
76.0 |
|
Qtrly Rev. Growth
|
6.2 |
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
3.00 |
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
P/E
|
20.34 |
|
P/E Growth Ratio
|
0.01 |
|
P/BV
|
3.25 |
|
P/S
|
|
|
P/CF
|
|
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
2019-04-02 |
|
Ex-Dividend Date
|
2018-08-17 |
|
Forward Dividend
|
1.270 |
|
Last Split Date
|
2014-01-09 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
